Publisher: Wiley-Blackwell

Related content
Volume 11, Number 8, September 2010

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Free Content HIV-1 proviral resistance mutations: usefulness in clinical practice
pp. 483-492(10)
Authors: Kabamba-Mukadi, B; Duquenne, A; Henrivaux, P; Musuamba, F; Ruelle, J; Yombi, J-C; Bodéus, M; Vandercam, B; Goubau, P

Favourites:Add to Favourites

Free Content No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial
pp. 493-501(9)
Authors: Calmy, A; Bloch, M; Wand, H; Delhumeau, C; Finlayson, R; Rafferty, M; Norris, R; Hirschel, B; Cooper, DA; Carr, A

Favourites:Add to Favourites

Free Content Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline
pp. 510-518(9)
Authors: Hosseinipour, MC; Kumwenda, JJ; Weigel, R; Brown, LB; Mzinganjira, D; Mhango, B; Eron, JJ; Phiri, S; van Oosterhout, JJ

Favourites:Add to Favourites

Free Content Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD)
pp. 519-529(11)
Authors: Oyomopito, R; Lee, MP; Phanuphak, P; Lim, PL; Ditangco, R; Zhou, J; Sirisanthana, T; Chen, YMA; Pujari, S; Kumarasamy, N; Sungkanuparph, S; Lee, CKC; Kamarulzaman, A; Oka, S; Zhang, FJ; Mean, CV; Merati, T; Tau, G; Smith, J; Li, PCK

Favourites:Add to Favourites

Free Content Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA)
pp. 530-534(5)
Authors: Di Vincenzo, P; Rusconi, S; Adorni, F; Vitiello, P; Maggiolo, F; Francisci, D; Di Biagio, A; Monno, L; Antinori, A; Boeri, E; Punzi, G; Perno, C-F; Callegaro, A; Bruzzone, B; Zazzi, M

Favourites:Add to Favourites

Free Content Effects of highly active antiretroviral therapy on vaccine-induced humoral immunity in HIV-infected adults
pp. 535-539(5)
Authors: González, R; Castro, P; García, F; Plana, M; Bayas, JM; Lafuente, S; Serrano, B; Mora, B; Argelich, R; Gatell, JM; Vilella, A

Favourites:Add to Favourites

Free Content HIV-associated obliterative portopathy (HIV-OP) underlies cryptogenic liver disease in HIV-seropositive patients
pp. 540-541(2)
Authors: Mallet, VO; Sultanik, PS; Vallet-Pichard, A; Pol, S

Favourites:Add to Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more